Last update 13 Jun 2026

IPR-1110

Overview

Basic Info

Drug Type
Chemical drugs
Synonyms
IPR 1110
Target
uPA x uPAR
Action
inhibitors
Mechanism
uPA inhibitors(Urokinase plasminogen activator inhibitors), uPAR inhibitors(Urokinase plasminogen activator surface receptor inhibitors)
Therapeutic Areas
NeoplasmsImmune System DiseasesRespiratory Diseases
Active Indication-
Inactive Indication
AsthmaNeoplasmsPulmonary Disease, Chronic Obstructive
Originator Organization-
Active Organization-
Inactive Organization
Boehringer Ingelheim GmbHBoehringer Ingelheim GmbHIndiana UniversityIndiana University
License Organization-
Drug Highest PhasePendingPreclinical
First Approval Date-
Regulation-

Related

100 Clinical Results associated with IPR-1110
Login to view more data
100 Translational Medicine associated with IPR-1110
Login to view more data
100 Patents (Medical) associated with IPR-1110
Login to view more data
100 Deals associated with IPR-1110
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
NeoplasmsPreclinical
United States
Indiana UniversityIndiana University
01 Dec 2020
AsthmaPreclinical
Germany
Boehringer Ingelheim GmbHBoehringer Ingelheim GmbH
26 Aug 2019
Pulmonary Disease, Chronic ObstructivePreclinical
Germany
Boehringer Ingelheim GmbHBoehringer Ingelheim GmbH
16 Aug 2019
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free